Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Planta Med. 2011 Jun;77(9):873-81. doi: 10.1055/s-0030-1270983. Epub 2011 Apr 6.
Chinese medicine (CM) has a long history of experience and proven successful treatment for chronic diseases and has also played an important role in the provision of health care in China. Patients with chronic diseases are happy to accept CM and physicians are willing to use CM to relieve patients suffering from chronic illnesses. The Chinese health authorities encourage CM development to meet the requirements for the treatment of chronic diseases. CM products are an essential part of medications that have a predominant role in the prevention and treatment of chronic diseases in China. A large number of CM clinical studies, including a substantial number of available randomized controlled trials and systematic reviews, have shown that CM is effective and safe in the treatment of chronic diseases. Although the efficacies of some evaluated CM therapies remain uncertain, it is worth assessing them by using CM pattern (Zheng or syndrome) differentiation to verify treatment outcomes. CM is considered to have a better safety profile compared to pharmaceutical chemicals, but inappropriate applications of CM also makes the safety issues a hot discussed subject. As a medical system, CM should be able to provide worldwide contribution for the patients who are suffering from chronic diseases. The application of CM pattern classification in diagnosis with corresponding prescribed treatment using herbal formulae in the relief of chronic diseases can be linked with modern biomedical parameters (biomarkers) as treatment outcomes. These outcome parameters, together with the patients' reported quality of life assessment, can provide innovative approaches for evidence-based estimation of the efficacy of CM treatment in chronic diseases.
中医药在慢性病治疗方面拥有丰富的经验和确凿的疗效,在中国的医疗保健中也发挥着重要作用。慢性病患者乐于接受中医药治疗,医生也愿意使用中医药来减轻慢性病患者的痛苦。中国卫生主管部门鼓励中医药的发展,以满足慢性病治疗的需求。中医药产品是药物的重要组成部分,在中国慢性病的预防和治疗中发挥着主要作用。大量中医药临床研究,包括大量现有的随机对照试验和系统评价,表明中医药在慢性病治疗中是有效和安全的。虽然一些评估的中医药疗法的疗效仍不确定,但通过使用中医药的证候(证或症)分类来评估治疗结果是值得的。与化药相比,中医药被认为具有更好的安全性,但中医药的不当应用也使安全性问题成为一个热议的话题。作为一种医疗体系,中医药应该能够为患有慢性病的患者提供全球贡献。将中医药的证候分类应用于诊断,并使用草药配方进行相应的治疗,可以将其与现代生物医学参数(生物标志物)作为治疗结果联系起来。这些结果参数,以及患者报告的生活质量评估,可以为基于证据的中医药治疗慢性病疗效评估提供创新方法。